GLP-1 (Semaglutide)
Metabolic age reduction; visceral fat clearance; cardiovascular risk reduction; neuroinflammation suppression
GLP-2
AdjacentResearch ongoing — see primary literature for current evidence.
Clinical Decision Framework
When evaluating GLP-1 (Semaglutide) versus GLP-2 for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize GLP-1 (Semaglutide):
Select GLP-1 (Semaglutide) when the primary clinical objective aligns with its core mechanism: glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.. This is particularly relevant for protocols focused on significant weight loss via appetite suppression and metabolic improvement..
When to prioritize GLP-2:
Conversely, GLP-2 is the superior choice when targeting intestinal hormone analog that promotes enterocyte proliferation, gut barrier integrity, and nutrient absorption., making it the preferred agent for gut health restoration, intestinal repair, and nutrient absorption optimization..
Begin Your Age Reversal Protocol for GLP-1 (Semaglutide) or GLP-2
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing